News and Insights
From the Medical Affairs Experts at Zipher
July 2021
Medical Affairs Unscripted Episode 7 Now Available
Starting from the clinical trials and ending with meeting the regulatory demands across various countries, bringing a product to market successfully has become increasingly difficult. Therefore, it is critical that an overall launch strategy is established and executed.
May 2021
Medical Affairs Unscripted Episode 6 Now Available
Measuring the impact of the Medical Affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today.
March 2021
Medical Affairs Unscripted Episode 5 Now Available
Zipher’s Medical Affairs unscripted features Dr. Zhen Su, an industry expert with over 20 years of experience and currently the Senior Vice President and Global Head of the Oncology Franchise for Merck, KGaA, Darmstadt, Germany to discuss how to develop the internal value of Medical Affairs as a strategic equal, improve cross-functional collaboration, and how to adapt to the virtual environment in this pandemic era and beyond.
January 2021
How Are Medical Affairs Organizations Proving Their Value?
Medical Affairs (MA) serves as a core scientific voice for the organization. With high competition and limited budget, it has grown increasingly more critical for Medical to meet their goals and key milestones at year-end.
December 2020
Top 12 Medical Affairs Tips
As we celebrate our 12th Anniversary, we'd like to share the top 12 Medical Affairs tips every life science company should implement to ensure successful outcomes!
October 2020
Medical Affairs Unscripted Episode 4.5 Now Available
Dr. Peg Crowley-Nowick, Founder & President of Zipher Medical Affairs is joined by Zipher’s own Julie Cahill, M.D., Vice President of Consulting and Medical Director Services to continue the conversation from Episode 4: Data Generation | The Intersection Between Medical Affairs and Clinical Development by expanding further on the need to identify data gaps and how organizations can work together to consider the full scope of research that can be used to fill those gaps.
